# Daniel Aletaha

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-aletaha/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,072 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 93 |
| i10-index | 280 |
| Last Known Institution | Medical University of Vienna |
| OpenAlex ID | https://openalex.org/A5061411814 |
| ORCID iD | https://orcid.org/0000-0003-2108-0030 |
| Works | 599 |

## Researcher papers

- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis-2/)
- [Diagnosis and Management of Rheumatoid Arthritis](https://scholariq.org/papers/diagnosis-and-management-of-rheumatoid-arthritis/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-3/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-2014-update-of-the-recommendations-of-an/)
- [American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials](https://scholariq.org/papers/american-college-of-rheumatology-european-league-against-rheumatism-provisional/)
- [European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update](https://scholariq.org/papers/european-league-against-rheumatism-eular-recommendations-for-the-management-of/)
- [2016 update of the EULAR recommendations for the management of early arthritis](https://scholariq.org/papers/2016-update-of-the-eular-recommendations-for-the-management-of-early-arthritis/)
- [2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations](https://scholariq.org/papers/2014-update-of-the-eular-standardised-operating-procedures-for-eular-endorsed/)
- [Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative](https://scholariq.org/papers/multinational-evidence-based-recommendations-for-the-diagnosis-and-management-of/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Medical University of Vienna](https://scholariq.org/institutions/medical-university-of-vienna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.